| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/12/2013 | CN103141531A Compound plant essential oil and application thereof |
| 06/12/2013 | CN102657666B Medical application of 1,2,3,4,6-O-pentagalloylglucose and composition thereof in preparation of demulcent medicaments |
| 06/12/2013 | CN102657612B GDNF-carrying microbubble preparation and method for making the same |
| 06/12/2013 | CN102600367B Medicament for treating brain injury sequelae |
| 06/12/2013 | CN102600228B Method for preparing gypenoside in gypenoside grains |
| 06/12/2013 | CN102579986B Chinese medicinal pain-removing mixture for treating migraine |
| 06/12/2013 | CN102579974B Chinese medicinal wearing bag for treating cerebral palsy |
| 06/12/2013 | CN102440973B Diphenhydramine citrate orally disintegrating tablet and preparation method thereof |
| 06/12/2013 | CN102429932B Method for extracting lucid ganoderma essence |
| 06/12/2013 | CN102378814B Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 06/12/2013 | CN102357149B Health product with sedative and hypnotic functions |
| 06/12/2013 | CN102309632B Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 06/12/2013 | CN102258719B Preparation method of traditional Chinese medicinal oral liquid preparation for treating children's cold |
| 06/12/2013 | CN102204893B Blonanserin dropping pill and preparation method thereof |
| 06/12/2013 | CN102140465B Human miR-1249 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102140462B Human miR-1260 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102105458B 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists |
| 06/12/2013 | CN102070582B 2, 3-dihydroxy cinnamomum lactone derivative and application thereof |
| 06/12/2013 | CN102060787B Tetramethylpyrazine ferulate crystals for suppressing platelet aggregation and thrombosis and preparation method thereof |
| 06/12/2013 | CN102015667B Aminodihydrothiazine derivatives as BACE inhibitors for the treatment of alzheimer's disease |
| 06/12/2013 | CN102008508B Eupolyphaga sinensis walker extract for inhibiting acetylcholinesterase and preparation method thereof |
| 06/12/2013 | CN102007133B 3-phenylpyrazolo[5,1-b]thiazole compounds |
| 06/12/2013 | CN101972242B Application of puerarin in preparation of drugs for treating P2X3 receptor-mediated acute pain |
| 06/12/2013 | CN101906054B N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof |
| 06/12/2013 | CN101897771B Medicine composition for preventing or treating neurasthenia |
| 06/12/2013 | CN101875931B siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application |
| 06/12/2013 | CN101797221B Oral drug delivery system comprising high viscosity liquid carrier materials |
| 06/12/2013 | CN101715437B Stereoisomers propofol therapeutic compounds |
| 06/12/2013 | CN101684106B Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 06/12/2013 | CN101679315B Piperazine salts as d3/d2 antagonists |
| 06/12/2013 | CN101641089B An extract |
| 06/12/2013 | CN101594861B Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/12/2013 | CN101554368B Tetrodotoxin composition formulation stable at room temperature and used for injection |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/12/2013 | CN101429184B Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 06/12/2013 | CN101421303B Improved protofibril selective antibodies and the use thereof |
| 06/12/2013 | CN101351544B Transplantation of glial restricted precursor-derived astrocytes for promotion of axon growth |
| 06/12/2013 | CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 06/12/2013 | CN101208311B Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461203 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/11/2013 | US8461151 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
| 06/11/2013 | US8461145 Dibenzoazepine and dibenzooxazepine TRPA1 agonists |
| 06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
| 06/11/2013 | US8460932 Method of treating a disorder by suicide gene therapy |
| 06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
| 06/11/2013 | US8460867 Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | US8460646 Methods and compositions for treating mammalian nerve tissue injuries |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2576393C Novel derivatives of 3,5-seco-4-norcholestane and use thereof |
| 06/11/2013 | CA2533690C Use of a polyamine-poor composition for the production of a medical human food |
| 06/11/2013 | CA2473864C Composition for use in treating patients suffering from movement disorder |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2406277C Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 06/11/2013 | CA2363705C Devices and methods for pain management |
| 06/09/2013 | CA2798549A1 Novel combination of 4-{3-¬cis-hexahydrocyclopenta¬c|pyrrol-2(1h)-yl|propoxy}benzamide and an nmda receptor antagonist and the pharmacutical compounds containing same |
| 06/06/2013 | WO2013082573A1 Acamprosate formulations, methods of using the same, and combinations comprising the same |
| 06/06/2013 | WO2013082551A1 Induced exon inclusion in spinal muscle atrophy |
| 06/06/2013 | WO2013082548A1 Oligonucleotides for treating expanded repeat diseases |
| 06/06/2013 | WO2013082286A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | WO2013082114A1 Use of p3 of bacteriophage as amyloid binding agents |
| 06/06/2013 | WO2013082102A1 Substituted 4 - phenyl - pyridines for the treatment of nk-1 receptor related diseases |
| 06/06/2013 | WO2013081706A1 Methods and compositions for increasing arylsulfatase a activity in the cns |
| 06/06/2013 | WO2013081420A2 Phenoxypropanol derivative and pharmaceutical composition containing same |
| 06/06/2013 | WO2013081419A1 Pharmaceutical composition for prevention or treatment of cognitive function disorders comprising spinosyn |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013081102A1 Ropinirole-containing adhesive patch |
| 06/06/2013 | WO2013081094A1 Imidazo[1,2-a]pyridine derivative and use thereof for medical purposes |
| 06/06/2013 | WO2013080271A1 Analgesic |
| 06/06/2013 | WO2013080265A1 Stabilization of s-adenosylmethionine with acid sodium metaphosphate |
| 06/06/2013 | WO2013080120A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 06/06/2013 | WO2013080046A1 Lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of at least one cns disorder |
| 06/06/2013 | WO2013080036A1 Azetidine-substituted quinoxaline-type piperidine compounds and uses thereof |
| 06/06/2013 | WO2013079873A1 Phacetoperane for the treatment of attention-deficit hyperactivity disorder |
| 06/06/2013 | WO2013079745A1 Compounds that inhibit aggregation of the beta amyloid peptide |
| 06/06/2013 | WO2013079624A1 Composition comprising vicenin-2 having a beneficial effect on neurological and/or cognitive function |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079460A1 Novel compounds |
| 06/06/2013 | WO2013079205A1 Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) |
| 06/06/2013 | WO2013079007A1 Donepezil pamoate, preparation methode and its use |
| 06/06/2013 | WO2013078608A1 Donepezil pamoate and methods of making and using the same |
| 06/06/2013 | WO2013057337A3 Composition capable of promoting the proliferation of neural stem cells |
| 06/06/2013 | WO2013043744A3 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 06/06/2013 | WO2013033037A3 Novel antiprion compounds |
| 06/06/2013 | WO2012177903A4 Methods of treating cognitive impairment |
| 06/06/2013 | WO2012137146A4 Means for concealing the flavour and smell of peptide hydrolysates |
| 06/06/2013 | US20130144062 Heteroaryl carboxamides |
| 06/06/2013 | US20130143967 Organosulfur compounds for the prevention and treatment of neurodegenerative diseases |
| 06/06/2013 | US20130143965 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/06/2013 | US20130143922 Thio compounds |
| 06/06/2013 | US20130143919 Pharmaceutical compositions and administrations thereof |
| 06/06/2013 | US20130143845 Vitamin d compounds and methods for enhancing muscle strength, and prevention and treatment of disease in human beings |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142794 Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS |
| 06/06/2013 | US20130142756 Methods of improving central nervous system functioning |